Request for Covid-19 Impact Assessment of this Report
The United States Malaria Vaccines market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Malaria Vaccines market, reaching US$ million by the year 2028. As for the Europe Malaria Vaccines landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Malaria Vaccines players cover GlaxoSmithKline Plc, Sanaria Inc, Nobelpharma Co, and Sumaya Biotech, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Malaria Vaccines market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Pre-Erythrocytic Vaccine
Erythrocytic Vaccine
Multi-antigen Vaccine
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Hospitals
Clinics
Community Centers
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
GlaxoSmithKline Plc
Sanaria Inc
Nobelpharma Co
Sumaya Biotech
GenVec
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Malaria Vaccines Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Malaria Vaccines by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Malaria Vaccines by Country/Region, 2017, 2022 & 2028
2.2 Malaria Vaccines Segment by Type
2.2.1 Pre-Erythrocytic Vaccine
2.2.2 Erythrocytic Vaccine
2.2.3 Multi-antigen Vaccine
2.3 Malaria Vaccines Sales by Type
2.3.1 Global Malaria Vaccines Sales Market Share by Type (2017-2022)
2.3.2 Global Malaria Vaccines Revenue and Market Share by Type (2017-2022)
2.3.3 Global Malaria Vaccines Sale Price by Type (2017-2022)
2.4 Malaria Vaccines Segment by Application
2.4.1 Hospitals
2.4.2 Clinics
2.4.3 Community Centers
2.5 Malaria Vaccines Sales by Application
2.5.1 Global Malaria Vaccines Sale Market Share by Application (2017-2022)
2.5.2 Global Malaria Vaccines Revenue and Market Share by Application (2017-2022)
2.5.3 Global Malaria Vaccines Sale Price by Application (2017-2022)
3 Global Malaria Vaccines by Company
3.1 Global Malaria Vaccines Breakdown Data by Company
3.1.1 Global Malaria Vaccines Annual Sales by Company (2020-2022)
3.1.2 Global Malaria Vaccines Sales Market Share by Company (2020-2022)
3.2 Global Malaria Vaccines Annual Revenue by Company (2020-2022)
3.2.1 Global Malaria Vaccines Revenue by Company (2020-2022)
3.2.2 Global Malaria Vaccines Revenue Market Share by Company (2020-2022)
3.3 Global Malaria Vaccines Sale Price by Company
3.4 Key Manufacturers Malaria Vaccines Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Malaria Vaccines Product Location Distribution
3.4.2 Players Malaria Vaccines Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Malaria Vaccines by Geographic Region
4.1 World Historic Malaria Vaccines Market Size by Geographic Region (2017-2022)
4.1.1 Global Malaria Vaccines Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Malaria Vaccines Annual Revenue by Geographic Region
4.2 World Historic Malaria Vaccines Market Size by Country/Region (2017-2022)
4.2.1 Global Malaria Vaccines Annual Sales by Country/Region (2017-2022)
4.2.2 Global Malaria Vaccines Annual Revenue by Country/Region
4.3 Americas Malaria Vaccines Sales Growth
4.4 APAC Malaria Vaccines Sales Growth
4.5 Europe Malaria Vaccines Sales Growth
4.6 Middle East & Africa Malaria Vaccines Sales Growth
5 Americas
5.1 Americas Malaria Vaccines Sales by Country
5.1.1 Americas Malaria Vaccines Sales by Country (2017-2022)
5.1.2 Americas Malaria Vaccines Revenue by Country (2017-2022)
5.2 Americas Malaria Vaccines Sales by Type
5.3 Americas Malaria Vaccines Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Malaria Vaccines Sales by Region
6.1.1 APAC Malaria Vaccines Sales by Region (2017-2022)
6.1.2 APAC Malaria Vaccines Revenue by Region (2017-2022)
6.2 APAC Malaria Vaccines Sales by Type
6.3 APAC Malaria Vaccines Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Malaria Vaccines by Country
7.1.1 Europe Malaria Vaccines Sales by Country (2017-2022)
7.1.2 Europe Malaria Vaccines Revenue by Country (2017-2022)
7.2 Europe Malaria Vaccines Sales by Type
7.3 Europe Malaria Vaccines Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Malaria Vaccines by Country
8.1.1 Middle East & Africa Malaria Vaccines Sales by Country (2017-2022)
8.1.2 Middle East & Africa Malaria Vaccines Revenue by Country (2017-2022)
8.2 Middle East & Africa Malaria Vaccines Sales by Type
8.3 Middle East & Africa Malaria Vaccines Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Malaria Vaccines
10.3 Manufacturing Process Analysis of Malaria Vaccines
10.4 Industry Chain Structure of Malaria Vaccines
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Malaria Vaccines Distributors
11.3 Malaria Vaccines Customer
12 World Forecast Review for Malaria Vaccines by Geographic Region
12.1 Global Malaria Vaccines Market Size Forecast by Region
12.1.1 Global Malaria Vaccines Forecast by Region (2023-2028)
12.1.2 Global Malaria Vaccines Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Malaria Vaccines Forecast by Type
12.7 Global Malaria Vaccines Forecast by Application
13 Key Players Analysis
13.1 GlaxoSmithKline Plc
13.1.1 GlaxoSmithKline Plc Company Information
13.1.2 GlaxoSmithKline Plc Malaria Vaccines Product Offered
13.1.3 GlaxoSmithKline Plc Malaria Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 GlaxoSmithKline Plc Main Business Overview
13.1.5 GlaxoSmithKline Plc Latest Developments
13.2 Sanaria Inc
13.2.1 Sanaria Inc Company Information
13.2.2 Sanaria Inc Malaria Vaccines Product Offered
13.2.3 Sanaria Inc Malaria Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Sanaria Inc Main Business Overview
13.2.5 Sanaria Inc Latest Developments
13.3 Nobelpharma Co
13.3.1 Nobelpharma Co Company Information
13.3.2 Nobelpharma Co Malaria Vaccines Product Offered
13.3.3 Nobelpharma Co Malaria Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Nobelpharma Co Main Business Overview
13.3.5 Nobelpharma Co Latest Developments
13.4 Sumaya Biotech
13.4.1 Sumaya Biotech Company Information
13.4.2 Sumaya Biotech Malaria Vaccines Product Offered
13.4.3 Sumaya Biotech Malaria Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Sumaya Biotech Main Business Overview
13.4.5 Sumaya Biotech Latest Developments
13.5 GenVec
13.5.1 GenVec Company Information
13.5.2 GenVec Malaria Vaccines Product Offered
13.5.3 GenVec Malaria Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 GenVec Main Business Overview
13.5.5 GenVec Latest Developments
14 Research Findings and Conclusion
Table 1. Malaria Vaccines Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Malaria Vaccines Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Pre-Erythrocytic Vaccine
Table 4. Major Players of Erythrocytic Vaccine
Table 5. Major Players of Multi-antigen Vaccine
Table 6. Global Malaria Vaccines Sales by Type (2017-2022) & (K Units)
Table 7. Global Malaria Vaccines Sales Market Share by Type (2017-2022)
Table 8. Global Malaria Vaccines Revenue by Type (2017-2022) & ($ million)
Table 9. Global Malaria Vaccines Revenue Market Share by Type (2017-2022)
Table 10. Global Malaria Vaccines Sale Price by Type (2017-2022) & (USD/Unit)
Table 11. Global Malaria Vaccines Sales by Application (2017-2022) & (K Units)
Table 12. Global Malaria Vaccines Sales Market Share by Application (2017-2022)
Table 13. Global Malaria Vaccines Revenue by Application (2017-2022)
Table 14. Global Malaria Vaccines Revenue Market Share by Application (2017-2022)
Table 15. Global Malaria Vaccines Sale Price by Application (2017-2022) & (USD/Unit)
Table 16. Global Malaria Vaccines Sales by Company (2020-2022) & (K Units)
Table 17. Global Malaria Vaccines Sales Market Share by Company (2020-2022)
Table 18. Global Malaria Vaccines Revenue by Company (2020-2022) ($ Millions)
Table 19. Global Malaria Vaccines Revenue Market Share by Company (2020-2022)
Table 20. Global Malaria Vaccines Sale Price by Company (2020-2022) & (USD/Unit)
Table 21. Key Manufacturers Malaria Vaccines Producing Area Distribution and Sales Area
Table 22. Players Malaria Vaccines Products Offered
Table 23. Malaria Vaccines Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Malaria Vaccines Sales by Geographic Region (2017-2022) & (K Units)
Table 27. Global Malaria Vaccines Sales Market Share Geographic Region (2017-2022)
Table 28. Global Malaria Vaccines Revenue by Geographic Region (2017-2022) & ($ millions)
Table 29. Global Malaria Vaccines Revenue Market Share by Geographic Region (2017-2022)
Table 30. Global Malaria Vaccines Sales by Country/Region (2017-2022) & (K Units)
Table 31. Global Malaria Vaccines Sales Market Share by Country/Region (2017-2022)
Table 32. Global Malaria Vaccines Revenue by Country/Region (2017-2022) & ($ millions)
Table 33. Global Malaria Vaccines Revenue Market Share by Country/Region (2017-2022)
Table 34. Americas Malaria Vaccines Sales by Country (2017-2022) & (K Units)
Table 35. Americas Malaria Vaccines Sales Market Share by Country (2017-2022)
Table 36. Americas Malaria Vaccines Revenue by Country (2017-2022) & ($ Millions)
Table 37. Americas Malaria Vaccines Revenue Market Share by Country (2017-2022)
Table 38. Americas Malaria Vaccines Sales by Type (2017-2022) & (K Units)
Table 39. Americas Malaria Vaccines Sales Market Share by Type (2017-2022)
Table 40. Americas Malaria Vaccines Sales by Application (2017-2022) & (K Units)
Table 41. Americas Malaria Vaccines Sales Market Share by Application (2017-2022)
Table 42. APAC Malaria Vaccines Sales by Region (2017-2022) & (K Units)
Table 43. APAC Malaria Vaccines Sales Market Share by Region (2017-2022)
Table 44. APAC Malaria Vaccines Revenue by Region (2017-2022) & ($ Millions)
Table 45. APAC Malaria Vaccines Revenue Market Share by Region (2017-2022)
Table 46. APAC Malaria Vaccines Sales by Type (2017-2022) & (K Units)
Table 47. APAC Malaria Vaccines Sales Market Share by Type (2017-2022)
Table 48. APAC Malaria Vaccines Sales by Application (2017-2022) & (K Units)
Table 49. APAC Malaria Vaccines Sales Market Share by Application (2017-2022)
Table 50. Europe Malaria Vaccines Sales by Country (2017-2022) & (K Units)
Table 51. Europe Malaria Vaccines Sales Market Share by Country (2017-2022)
Table 52. Europe Malaria Vaccines Revenue by Country (2017-2022) & ($ Millions)
Table 53. Europe Malaria Vaccines Revenue Market Share by Country (2017-2022)
Table 54. Europe Malaria Vaccines Sales by Type (2017-2022) & (K Units)
Table 55. Europe Malaria Vaccines Sales Market Share by Type (2017-2022)
Table 56. Europe Malaria Vaccines Sales by Application (2017-2022) & (K Units)
Table 57. Europe Malaria Vaccines Sales Market Share by Application (2017-2022)
Table 58. Middle East & Africa Malaria Vaccines Sales by Country (2017-2022) & (K Units)
Table 59. Middle East & Africa Malaria Vaccines Sales Market Share by Country (2017-2022)
Table 60. Middle East & Africa Malaria Vaccines Revenue by Country (2017-2022) & ($ Millions)
Table 61. Middle East & Africa Malaria Vaccines Revenue Market Share by Country (2017-2022)
Table 62. Middle East & Africa Malaria Vaccines Sales by Type (2017-2022) & (K Units)
Table 63. Middle East & Africa Malaria Vaccines Sales Market Share by Type (2017-2022)
Table 64. Middle East & Africa Malaria Vaccines Sales by Application (2017-2022) & (K Units)
Table 65. Middle East & Africa Malaria Vaccines Sales Market Share by Application (2017-2022)
Table 66. Key Market Drivers & Growth Opportunities of Malaria Vaccines
Table 67. Key Market Challenges & Risks of Malaria Vaccines
Table 68. Key Industry Trends of Malaria Vaccines
Table 69. Malaria Vaccines Raw Material
Table 70. Key Suppliers of Raw Materials
Table 71. Malaria Vaccines Distributors List
Table 72. Malaria Vaccines Customer List
Table 73. Global Malaria Vaccines Sales Forecast by Region (2023-2028) & (K Units)
Table 74. Global Malaria Vaccines Sales Market Forecast by Region
Table 75. Global Malaria Vaccines Revenue Forecast by Region (2023-2028) & ($ millions)
Table 76. Global Malaria Vaccines Revenue Market Share Forecast by Region (2023-2028)
Table 77. Americas Malaria Vaccines Sales Forecast by Country (2023-2028) & (K Units)
Table 78. Americas Malaria Vaccines Revenue Forecast by Country (2023-2028) & ($ millions)
Table 79. APAC Malaria Vaccines Sales Forecast by Region (2023-2028) & (K Units)
Table 80. APAC Malaria Vaccines Revenue Forecast by Region (2023-2028) & ($ millions)
Table 81. Europe Malaria Vaccines Sales Forecast by Country (2023-2028) & (K Units)
Table 82. Europe Malaria Vaccines Revenue Forecast by Country (2023-2028) & ($ millions)
Table 83. Middle East & Africa Malaria Vaccines Sales Forecast by Country (2023-2028) & (K Units)
Table 84. Middle East & Africa Malaria Vaccines Revenue Forecast by Country (2023-2028) & ($ millions)
Table 85. Global Malaria Vaccines Sales Forecast by Type (2023-2028) & (K Units)
Table 86. Global Malaria Vaccines Sales Market Share Forecast by Type (2023-2028)
Table 87. Global Malaria Vaccines Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 88. Global Malaria Vaccines Revenue Market Share Forecast by Type (2023-2028)
Table 89. Global Malaria Vaccines Sales Forecast by Application (2023-2028) & (K Units)
Table 90. Global Malaria Vaccines Sales Market Share Forecast by Application (2023-2028)
Table 91. Global Malaria Vaccines Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 92. Global Malaria Vaccines Revenue Market Share Forecast by Application (2023-2028)
Table 93. GlaxoSmithKline Plc Basic Information, Malaria Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 94. GlaxoSmithKline Plc Malaria Vaccines Product Offered
Table 95. GlaxoSmithKline Plc Malaria Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 96. GlaxoSmithKline Plc Main Business
Table 97. GlaxoSmithKline Plc Latest Developments
Table 98. Sanaria Inc Basic Information, Malaria Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 99. Sanaria Inc Malaria Vaccines Product Offered
Table 100. Sanaria Inc Malaria Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 101. Sanaria Inc Main Business
Table 102. Sanaria Inc Latest Developments
Table 103. Nobelpharma Co Basic Information, Malaria Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 104. Nobelpharma Co Malaria Vaccines Product Offered
Table 105. Nobelpharma Co Malaria Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 106. Nobelpharma Co Main Business
Table 107. Nobelpharma Co Latest Developments
Table 108. Sumaya Biotech Basic Information, Malaria Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 109. Sumaya Biotech Malaria Vaccines Product Offered
Table 110. Sumaya Biotech Malaria Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 111. Sumaya Biotech Main Business
Table 112. Sumaya Biotech Latest Developments
Table 113. GenVec Basic Information, Malaria Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 114. GenVec Malaria Vaccines Product Offered
Table 115. GenVec Malaria Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 116. GenVec Main Business
Table 117. GenVec Latest Developments
List of Figures
Figure 1. Picture of Malaria Vaccines
Figure 2. Malaria Vaccines Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Malaria Vaccines Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Malaria Vaccines Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Malaria Vaccines Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Pre-Erythrocytic Vaccine
Figure 10. Product Picture of Erythrocytic Vaccine
Figure 11. Product Picture of Multi-antigen Vaccine
Figure 12. Global Malaria Vaccines Sales Market Share by Type in 2021
Figure 13. Global Malaria Vaccines Revenue Market Share by Type (2017-2022)
Figure 14. Malaria Vaccines Consumed in Hospitals
Figure 15. Global Malaria Vaccines Market: Hospitals (2017-2022) & (K Units)
Figure 16. Malaria Vaccines Consumed in Clinics
Figure 17. Global Malaria Vaccines Market: Clinics (2017-2022) & (K Units)
Figure 18. Malaria Vaccines Consumed in Community Centers
Figure 19. Global Malaria Vaccines Market: Community Centers (2017-2022) & (K Units)
Figure 20. Global Malaria Vaccines Sales Market Share by Application (2017-2022)
Figure 21. Global Malaria Vaccines Revenue Market Share by Application in 2021
Figure 22. Malaria Vaccines Revenue Market by Company in 2021 ($ Million)
Figure 23. Global Malaria Vaccines Revenue Market Share by Company in 2021
Figure 24. Global Malaria Vaccines Sales Market Share by Geographic Region (2017-2022)
Figure 25. Global Malaria Vaccines Revenue Market Share by Geographic Region in 2021
Figure 26. Global Malaria Vaccines Sales Market Share by Region (2017-2022)
Figure 27. Global Malaria Vaccines Revenue Market Share by Country/Region in 2021
Figure 28. Americas Malaria Vaccines Sales 2017-2022 (K Units)
Figure 29. Americas Malaria Vaccines Revenue 2017-2022 ($ Millions)
Figure 30. APAC Malaria Vaccines Sales 2017-2022 (K Units)
Figure 31. APAC Malaria Vaccines Revenue 2017-2022 ($ Millions)
Figure 32. Europe Malaria Vaccines Sales 2017-2022 (K Units)
Figure 33. Europe Malaria Vaccines Revenue 2017-2022 ($ Millions)
Figure 34. Middle East & Africa Malaria Vaccines Sales 2017-2022 (K Units)
Figure 35. Middle East & Africa Malaria Vaccines Revenue 2017-2022 ($ Millions)
Figure 36. Americas Malaria Vaccines Sales Market Share by Country in 2021
Figure 37. Americas Malaria Vaccines Revenue Market Share by Country in 2021
Figure 38. United States Malaria Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 39. Canada Malaria Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 40. Mexico Malaria Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 41. Brazil Malaria Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 42. APAC Malaria Vaccines Sales Market Share by Region in 2021
Figure 43. APAC Malaria Vaccines Revenue Market Share by Regions in 2021
Figure 44. China Malaria Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 45. Japan Malaria Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 46. South Korea Malaria Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 47. Southeast Asia Malaria Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 48. India Malaria Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 49. Australia Malaria Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 50. Europe Malaria Vaccines Sales Market Share by Country in 2021
Figure 51. Europe Malaria Vaccines Revenue Market Share by Country in 2021
Figure 52. Germany Malaria Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 53. France Malaria Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 54. UK Malaria Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 55. Italy Malaria Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 56. Russia Malaria Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 57. Middle East & Africa Malaria Vaccines Sales Market Share by Country in 2021
Figure 58. Middle East & Africa Malaria Vaccines Revenue Market Share by Country in 2021
Figure 59. Egypt Malaria Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 60. South Africa Malaria Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 61. Israel Malaria Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 62. Turkey Malaria Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 63. GCC Country Malaria Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 64. Manufacturing Cost Structure Analysis of Malaria Vaccines in 2021
Figure 65. Manufacturing Process Analysis of Malaria Vaccines
Figure 66. Industry Chain Structure of Malaria Vaccines
Figure 67. Channels of Distribution
Figure 68. Distributors Profiles
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...